Standout Papers

Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disea... 2018 2026 2020 2023 427
  1. Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial) (2018)
    Mohammad Shafi Kuchay, Sonal Krishan et al. Diabetes Care

Immediate Impact

64 standout
Sub-graph 1 of 21

Citing Papers

A Phase 2 Randomized Trial of Survodutide in MASH and Fibrosis
2024 Standout
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Standout
1 intermediate paper

Works of Khalid Farooqui being referenced

Effect of dulaglutide on liver fat in patients with type 2 diabetes and NAFLD: randomised controlled trial (D-LIFT trial)
2020
Effect of Empagliflozin on Liver Fat in Patients With Type 2 Diabetes and Nonalcoholic Fatty Liver Disease: A Randomized Controlled Trial (E-LIFT Trial)
2018 Standout

Author Peers

Author Last Decade Papers Cites
Khalid Farooqui 541 107 261 476 29 905
Sunil Kumar Mishra 577 90 227 714 22 1.1k
Enver Dolar 194 57 269 464 49 907
Satılmış Bilgin 235 97 133 386 36 1.1k
Christine Carter‐Kent 466 47 223 947 13 1.1k
Felix Grabherr 194 74 138 576 35 1.1k
Ahmet Tüzün 248 20 231 370 26 897
Steven C. Lin 189 55 164 523 21 876
Atakan Yeşıl 185 42 122 417 27 766
I A Rajkovic 164 69 173 304 23 909
Claudia Della Corte 441 17 330 754 54 1.1k

All Works

Loading papers...

Rankless by CCL
2026